On January 30, 2025 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will participate at the following investor conferences in February (Press release, UroGen Pharma, JAN 30, 2025, View Source [SID1234649966]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Securities SMID Cap Biotech Conference

Date / Time:

February 5, 2025 at 10:30 AM ET

Format:

Presentation and 1×1 investor meetings

Location:

New York, NY

Webcast Link:

here

Oppenheimer 35th Annual Healthcare Life Sciences Conference

Date / Time:

February 11, 2025 at 1:20 PM ET

Format:

Presentation and 1×1 investor meetings

Location:

Virtual

Webcast Link:

here

Webcasts from the conferences will also be available on UroGen’s Investor Relations website. A replay will be available on the site for approximately 90 days.